Antidepressant escitalopram more effective at preventing relapse, analysis finds
A new analysis published in The Lancet Psychiatry suggests that the antidepressant escitalopram is more effective than other common medications at preventing depression relapse. While the findings are significant, experts emphasize that individual treatment plans should still be determined through consultation with a doctor.
Why it matters
It provides evidence-based guidance for clinicians and patients managing long-term depression, potentially improving treatment outcomes for millions.
Image source, Getty Images By Michelle Roberts Digital health editor Published 28 minutes ago One drug comes out top in a large analysis , external of how effective antidepressants are at keeping patients free of symptoms of depression.
Escitalopram performed best at preventing patients from relapsing in a study involving nearly 10,000 people prescribed different medications for up to a year.
Two other pills - agomelatine and duloxetine - came next, while prozac (also known as fluoxetine) ranked just below them.
Experts stress the findings don't mean that everyone with severe depression should switch to escitalopram, or that other antidepressants aren't any good, because all the drugs can work and each has its pros and cons.
Depression is common, affecting around one in six people in the UK. With the right treatment and support, people can make a good recovery although for some their depression can return.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in